DKBmed Radio

Dr. Paul Auwaerter continues his interview with Dr. Christian Hermansen about COVID-19 vaccine distribution. Topics: *How mass vaccination sites can overcome distribution challenges *Transparent communication about the available vaccines *Handling ethical questions about the Johnson & Johnson vaccine *Vaccine distribution for COVID-recovered patients *Patient and provider response to monoclonal antibodies 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-12-21-episode/eval  

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  

Christian Hermansen, MD, MBA, Regional Medical Director, LGHP Academic Region, Managing Physician, Family Medicine Downtown, Ambulatory Clinical Director, LGHP Family Medicine Residency Program 

See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter interviews Dr. Christian Hermansen about COVID-19 vaccine distribution. Topics: *Distributing vaccines at one of the largest residency programs in the country *Effective vaccine communication strategies *The balance between getting vaccines out, and prioritizing people at-risk  *Real-world challenges of vaccine distribution 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-10-21-episode/eval  

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  

Christian Hermansen, MD, MBA, Regional Medical Director, LGHP Academic Region, Managing Physician, Family Medicine Downtown, Ambulatory Clinical Director, LGHP Family Medicine Residency Program 

See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter continues his interview with Malia Jones, PhD, MPH about COVID-19 herd immunity. Topics: *Will COVID-19 herd immunity look like influenza “herd immunity”? *Issues with herd immunity through native infection *Native immunity vs. Vaccine immunity *Can we eradicate COVID-19? 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-5-21-episode/eval  

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  

Malia Jones, PhD, MPH, Assistant/Associate Scientist in Health Geography, Applied Population Laboratory, Department of Community and Environmental Sociology, University of Wisconsin-Madison 

See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter interviews Malia Jones, PhD, MPH about COVID-19 herd immunity. Topics: *Differences between herd immunity and transmission rate (Rt) *How vaccines accelerate herd immunity *Similarities in herd immunity between measles and COVID-19 *Communicating the importance of vaccine adoption 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-3-21-episode/eval  

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  

Malia Jones, PhD, MPH, Assistant/Associate Scientist in Health Geography, Applied Population Laboratory, Department of Community and Environmental Sociology, University of Wisconsin-Madison 

See acast.com/privacy for privacy and opt-out information.

Dr. Auwaerter describes our fundamental understanding of COVID-19 transmission, disease course, and potential routes for treatment. Topics: *SARS-CoV-2 pathogenesis *Viral variants: UK, Japan/Brazil, and South Africa *Where do infections occur? *Disease burden and risk factors *COVID-19 phases and interventions 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-26-21-episode/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine 

See acast.com/privacy for privacy and opt-out information.

Drs. Paul Auwaerter and Charles Vega discuss the various COVID-19 treatment options and answer your questions. Topics: *Understanding treatment options for ambulatory and hospitalized patients *Accurately identifying patients eligible for monoclonal antibodies *Understanding when, how, and why various treatments work *Describing the safety and efficacy of various treatments 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-17-2021-frontline-treatments-with-q-a/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty 

Presenting faculty:

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA) and Professor of Medicine at Johns Hopkins University School of Medicine   

Charles Vega, MD, FAAFP, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education at UC Irvine School of Medicine, and Director, UC Irvine Program in Medical Education for the Latino Community

See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the latest developments in COVID-19 vaccines. Topics: *Breaking news: the latest on the new Johnson & Johnson vaccine *Are variants impacting vaccine performance? *Explanations for the recent decrease in cases *The better vaccination strategy: one dose or two doses? 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-24-21-episode/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine 

See acast.com/privacy for privacy and opt-out information.

Arron Berry, RN, BSN, CCRN, PHRN, CFRN discusses presentation, treatment, and management of Multisystem Inflammatory Syndrome in Children (MIS-C). Topics: *Defining MIS-C and presentation *Management of MIS-C patients *Impact of co-morbidities on pediatric patients with COVID and MIS-C *Lab findings and statistics on MIS-C cases 

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-19-2021-pediatric-covid-19-part-2/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/  

Presenting faculty: Arron Berry, RN, BSN, CCRN, PHRN, CFRN, Johns Hopkins – Lifeline Critical Care Transport, Nurse Clinician III 

See acast.com/privacy for privacy and opt-out information.

Arron Berry, RN, BSN, CCRN, PHRN, CFRN discusses presentation, treatment, and management of pediatric COVID-19. Topics: *Treatment options for pediatric COVID-19 patients *Managing mild to moderate pediatric COVID-19 at home *Lab findings from pediatric COVID-19 *Statistics on pediatric COVID-19 

Post-test for CME/CE credit: https://covid19.dkbmed.com/#episode-2-12

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/  

Presenting faculty: Arron Berry, RN, BSN, CCRN, PHRN, CFRN, Johns Hopkins – Lifeline Critical Care Transport, Nurse Clinician III 

See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter answers your COVID-19 questions. Topics: *New treatments receiving emergency use authorization *Taking NSAIDS before/after vaccination *Vaccine efficacy against new strain variants *What you should know about monoclonal antibodies *Is there a role for colchicine? 

Post-test for CME/CE credit: https://covid19.dkbmed.com/#eval-test-2-10

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/

Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine 

See acast.com/privacy for privacy and opt-out information.